Diabetes Clinical Trials

408 recruiting

Diabetes Trials at a Glance

1,736 actively recruiting trials for diabetes are listed on ClinicalTrialsFinder across 6 cities in 86 countries. The largest study group is Not Applicable with 770 trials, with the heaviest enrollment activity in Boston, Houston, and Aurora. Lead sponsors running diabetes studies include Eli Lilly and Company, University of Colorado, Denver, and Novo Nordisk A/S.

Treatments under study

About Diabetes Clinical Trials

Looking for clinical trials for Diabetes? There are currently 408 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,736 trials

Recruiting

Taste Bud-Derived Stem Cells in Humans

Diabetes
National Institute on Aging (NIA)250 enrolled1 locationNCT03366168
Recruiting

Genetics of Type 2 Diabetes in West Africans

HypertensionDiabetes
National Human Genome Research Institute (NHGRI)10,000 enrolled5 locationsNCT00837122
Recruiting

Personalized Environment and Genes Study

AsthmaDiabetesHeart Disease
National Institute of Environmental Health Sciences (NIEHS)25,000 enrolled1 locationNCT00341237
Recruiting

Diabetes and Heart Disease Risk in Blacks

ObesityCardiovascular DiseasesHypertension+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,000 enrolled1 locationNCT00001853
Recruiting

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

Diabetes Mellitus, Type 1
Tandem Diabetes Care, Inc.350 enrolled21 locationsNCT07211126
Recruiting
Phase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana90 enrolled1 locationNCT06613854
Recruiting

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

Type 2 DiabetesHeart Failure With Preserved Ejection Fraction
University of Leicester60 enrolled1 locationNCT06652763
Recruiting

Genetic Studies of Insulin and Diabetes

Diabetes MellitusSevere Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1,200 enrolled1 locationNCT00001987
Recruiting
Not Applicable

The eHealth Diabetes Remission Trial

Diabetes Mellitus, Type 2
Umeå University106 enrolled3 locationsNCT05491005
Recruiting

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

Type 2 Diabetes Mellitus
Servier Russia300 enrolled1 locationNCT07433192
Recruiting
Phase 3

Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Obesity With DiabetesOverweight With Diabetes
Kailera1,700 enrolled37 locationsNCT07284901
Recruiting
Phase 4

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

Type 1 DiabetesPregnancy, High Risk
Ohio State University44 enrolled1 locationNCT07293715
Recruiting
Phase 1

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd.60 enrolled1 locationNCT07489482
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting

Urinary Vitamin C Loss in Diabetic Subjects

Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5,000 enrolled1 locationNCT00071526
Recruiting
Not Applicable

Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia

InflammationNutritionDiabetes Prevention+1 more
University of Bologna40 enrolled1 locationNCT07198789
Recruiting
Not Applicable

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Diabetes Mellitus, Type 2
Stanford University119,680 enrolled4 locationsNCT06251323
Recruiting
Early Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Stage 3 Type 1 Diabetes
City of Hope Medical Center6 enrolled1 locationNCT07395050
Recruiting
Not Applicable

The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control

Diabetes MellitusLipohypertrophy
University of British Columbia100 enrolled1 locationNCT05377268
Recruiting
Not Applicable

Prebiotics in Patients With Type 1 Diabetes

Type 1 Diabetes
University of Calgary144 enrolled3 locationsNCT04963777